INBRAIN Neuroelectronics
INBRAIN Neuroelectronics is a pioneering health-tech company focused on developing the next generation of neural interfaces using graphene technology. Founded as a spin-off from the Catalan Institute of Nanoscience and Nanotechnology (ICN2), the company aims to treat brain-related disorders such as Parkinson's and epilepsy through high-resolution, bidirectional brain-computer interfaces that decode and modulate neural signals with unprecedented precision. Headquartered in Barcelona, INBRAIN operates at the intersection of nanotechnology, neuroscience, and artificial intelligence. The company offers a highly international and multidisciplinary environment, making it an attractive destination for global experts in MEMS, electronics, and clinical operations looking to work on cutting-edge medical devices in one of Europe's primary biotech hubs.
Company History
Founded in 2019 as a spin-off from the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA. It was established to commercialize graphene-based neural interface technology developed by leading researchers in the field.
For International Professionals
- Headquartered in Barcelona, a major European hub for life sciences and biotechnology.
- Operates in the high-growth field of Brain-Computer Interfaces (BCI) using proprietary graphene technology.
- Multidisciplinary team environment combining nanotechnology, software engineering, and clinical research.
- Actively recruits international talent for specialized roles in MEMS engineering and neurotechnology.